Local News: Princeton, TX 

 | 

Sign Up

 | 

Sign In

Metformin (generic), Glucophage

Metformin (generic), Glucophage News Editors

News Widget

Display the Metformin (generic), Glucophage news headlines on your website.

Get the Topix Headlines Widget

Share & bookmark

RSS icon mobile icon

Metformin (generic), Glucophage News

News on Metformin (generic), Glucophage continually updated from thousands of sources around the net.

1 hr ago | CiteULike

Metformin Represses Self-Renewal of the Human Breast Carcinoma Stem...

Metformin, a Type II diabetic treatment drug, which inhibits transcription of gluconeogenesis genes, has recently been shown to lower the risk of some diabetes-related tumors, including breast cancer.

Comment?

Related Topix: Medicine, Medication, Health, Breast Cancer, Diabetes, Stem Cell Research, Science / Technology

Sat Feb 11, 2012

CiteULike

Effects of Exenatide Plus Rosiglitazone on I2-Cell Function and...

OBJECTIVE Study the effects of exenatide plus rosiglitazone on I2-cell function and insulin sensitivity using hyperglycemic and euglycemic insulin clamp techniques in participants with type 2 diabetes on metformin.RESEARCH DESIGN AND METHODS In this 20-week, randomized, open-label, multicenter study, participants continued their metformin regimen ... (more)

Comment?

Related Topix: Avandia, Rosiglitazone (generic), Medicine, Medication, Insulin (generic), Humulin, Novolin, Diabetes, Health

Fri Feb 10, 2012

Diabetes Self Management

FDA Approves Combo Type 2 Medicine

On the heels of its recent approval of the injectable drug Bydureon, the US Food and Drug Administration has approved linagliptin/metformin hydrochloride , an oral medicine for Type 2 diabetes manufactured by Boehringer Ingelheim Pharmaceuticals, Inc., and Eli Lilly and Company.

Comment?

Related Topix: Medicine, Medication, Diabetes, Health, Insulin (generic), Humulin, Novolin, Glyburide (generic), Micronase, Diabeta, Glucotrol, Glipizide (generic)

Thu Feb 09, 2012

CiteULike

Long term treatment with metformin in patients with type 2 diabetes...

Long term treatment with metformin in patients with type 2 diabetes and risk of vitamin B-12 deficiency: randomised placebo controlled trial by: Jolien de Jager , Adriaan Kooy , Philippe Lehert , Michiel G. WulffelA© , Jan van der Kolk , DaniA l Bets , Joop Verburg , Ab J. M. Donker , Coen D. A. Stehouwer To insert individual citation into a ... (more)

Comment?

Related Topix: Medicine, Medication, Health, Diabetes

Wed Feb 08, 2012

Hartford Courant

Jim Shea: Can You Pronounce Hydrochlorothiazide?

This, of course, is a topic to which everyone can relate. The only baby boomers who don't have something to moan and groan about at this stage are the ones who are no longer with us.

Comment?

Related Topix: Hydrochlorothiazide (generic), Medicine, Medication, Ansonia, CT

P&T Community

ACP Recommends Metformin as First Medication to Treat Type 2 Diabetes

The American College of Physicians recommends that metformin be the first medication used to treat type 2 diabetes when diet, exercise and weight loss do not improve blood sugar, according to a new clinical practice guideline.

Comment?

Related Topix: Medicine, Medication, Diabetes, Health, Life, Food, Dieting

Drugs.com

Health Tip: Coping With Migraines During Pregnancy

At the same time, some migraine medicines can cause birth defects, so medical experts advise pregnant women not to use them.

Comment?

Related Topix: Medicine, Medication

Tue Feb 07, 2012

MediLexicon

News From The Annals Of Internal Medicine: Feb. 7 2012

ACP also recommends that clinicians add a second drug to metformin when treatment with metformin and lifestyle changes fail to control blood sugar levels.

Comment?

Related Topix: Medicine, Diabetes, Health, Medication, Ovarian Cancer

Mon Feb 06, 2012

HealthCentral

Update on combination pills for people witha

Recently, several more combination diabetes pills have become available, and I think I ought to update my previous essay on "Combination pills for type 2 diabetes" to include the new combo pills.

Comment?

Related Topix: Medicine, Health, Diabetes, Medication

IVillage

Metformin Preferred Drug for Type 2 Diabetes, Experts Say

MONDAY, Feb. 6 -- When it comes to the treatment of type 2 diabetes, the first line of defense is lifestyle changes such as losing weight and exercising more often.

Comment?

Related Topix: Medicine, Diabetes, Health, Medication

BioSpace

Depomed, Inc. Announces FDA Approval of Merck & Co., Inc.'s...

Depomed, Inc. Announces FDA Approval of Merck & Co., Inc. 's JANUMET XR That Accesses Depomed Patents Licensed to Merck MENLO PARK, Calif., Feb.

Comment?

Related Topix: Biotech, Merck , DepoMed, Startups, Medicine, Healthcare Industry, Food and Drug Administration, Medication, Diabetes, Health

Drugs.com

Health Tip: How to Protect Seniors From Injury

Creating a home safety checklist can help seniors prevent injuries and let them prepare if they happen to fall or hurt themselves.

Comment?

Related Topix: Medicine, Rheumatrex, Methotrexate (generic)

Fri Feb 03, 2012

Benzinga

Depomed Announces Fda Approval of Merck's Janumet XR That...

Depomed, Inc. today announced that Merck disclosed on February 2, 2012 that the U.S. Food and Drug Administration approved JANUMETA XR tablets, a new treatment for type 2 diabetes that combines sitagliptin, which is the active component of JANUVIAA , with extended-release metformin.

Comment?

Related Topix: DepoMed, Startups, Food and Drug Administration, Medicine, Medication, Diabetes, Health

Drug Store News

New diabetes drug launches show primary care market still strong

WHAT IT MEANS AND WHY IT'S IMPORTANT - For all the fears about the patent cliff, at least one disease state seems to be on the up-and-up in terms of new drug development and new products.

Comment?

Related Topix: Medicine, Diabetes, Health, Biotech, Healthcare Industry, Medication, Eli Lilly

Thu Feb 02, 2012

NorthJersey.com

Merck wins approval for extended release Janumet

Drugmaker Merck & Co Inc. said Thursday it received U.S. approval for an extended-release version of its diabetes drug Janumet designed to be taken once a day, instead of twice a day.

Comment?

Related Topix: Biotech, Merck , Medicine, Healthcare Industry, Medication

TheStreet.com

Merck's Risky Cost Cutting Move

NEW YORK -- When good earnings come about as the result of cost cuts, exhilaration is woefully misplaced.

Comment?

Related Topix: TheStreet, Medicine, Medication, Diabetes, Health

Drugs.com

Health Tip: Talk to Teens About Distracted Driving

Become familiar with your state's laws about distracted driving, and educate your teen about the legal consequences of distracted driving.

Comment?

Related Topix: Medicine, Rheumatrex, Methotrexate (generic)

Wed Feb 01, 2012

American Academy of Family Physicians

News in Brief: Week of Jan. 30-Feb. 3

According to a recent study report published in the Annals of Internal Medicine , not all clinical practice guidelines on the use of oral medications for type 2 diabetes are consistent with the findings of a systematic review of the available scientific evidence that was funded by the Agency for Healthcare Research and Quality .

Comment?

Related Topix: Medicine, Diabetes, Health, Medication, Heart Failure

Drugs.com

FDA Approves Jentadueto (linagliptin/metformin hydrochloride) for the ...

RIDGEFIELD, Conn., and INDIANAPOLIS, Jan. 30, 2012 /PRNewswire/ -- Boehringer Ingelheim Pharmaceuticals, Inc.

Comment?

Related Topix: Medicine, Medication, Biotech, Eli Lilly, Healthcare Industry, Food and Drug Administration, Diabetes, Health, Fasting

Tue Jan 31, 2012

Mental Help Net

Popular Diabetes Drug Might Cut Pancreatic Cancer Risk: Study

TUESDAY, Jan. 31 -- A new Swiss-American study indicates that long-term use of the popular diabetes medication metformin may lower the risk of developing pancreatic cancer, at least among women.

Comment?

Related Topix: Medicine, Medication, Insulin (generic), Humulin, Novolin

Also on Topix